Completed NA INTERVENTIONAL 2-arm NCT01157026

A Pilot Clinical Trial With Tocotrienol on Breast Cancer (BC)

Effectiveness of Tocotrienol-rich Fraction Combined With Tamoxifen in the Management of Women With Early Breast Cancer: A Pilot Clinical Trial

Sponsor: Malaysia Palm Oil Board

Conditions Breast Cancer

Interventions Tocotrienol Rich Fraction (TRF) placebo plus tamoxifen

Updated 5 times since 2017 Last updated: Jul 2, 2010 Started: Nov 30, 2001 Primary completion: Nov 30, 2006 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer, this trial is completed. The trial is conducted by Malaysia Palm Oil Board and has accumulated 5 data snapshots since 2001. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Malaysia Palm Oil Board

Data source: Malaysia Palm Oil Board

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kajang, Malaysia